Ascentage Pharma Group International
AAPG | NASDAQ
$15.86
$0 (0.00%)
Sep 22, 2026, 12:31 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -13.53 | -23.67 | -2.35 | -2.24 | -2.25 | -2.26 |
PEG Ratio | -0.09 | 0.26 | 1.12 | -0.25 | 1.01 | 0.04 |
PS Ratio | 29.25 | 9.77 | 9.80 | 9.42 | 62.95 | 122.92 |
PB Ratio | 12.33 | 36.26 | 36.02 | 4.83 | 1.42 | 1.81 |
P/FCF Ratio | -13.59 | -70.62 | -2.78 | -2.22 | -1.69 | -1.78 |
P/OCF Ratio | -13.91 | -86.02 | -3 | -3.02 | -2.91 | -2.51 |
OCF/S Ratio | -210.24 | -11.36 | -327.09 | -311.82 | -2.17K | -4.9K |
Debt / Equity Ratio | 1.49 | 6.32 | 29.72 | 4.39 | 0.88 | 0.63 |
Quick Ratio | 1.77 | 1.26 | 1.42 | 1.85 | 5.21 | 3.91 |
Current Ratio | 1.79 | 1.26 | 1.44 | 1.86 | 5.22 | 3.91 |
Asset Turnover | 0.14 | 0.37 | 0.09 | 0.07 | 0.01 | 0.01 |
Interest Coverage | -22.42 | -5.74 | -9.08 | -16.10 | -51.99 | -106.15 |
Return on Equity | -91.22% | -153.46% | -1.53K% | -216.05% | -63.37% | -80.04% |
Return on Assets | -30.48% | -15.49% | -37.02% | -31.20% | -26.61% | -39.14% |
Return on Invested Capital | -33.26% | -16.58% | -39.67% | -34.28% | -31.11% | -44.10% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 76.41% | 97.03% | 86.24% | 89.51% | 88.08% | 84.21% |
Net Profit Margin | -216.47% | -41.34% | -416.98% | -421.02% | -2.8K% | -5.44K% |
Pretax Profit Margin | -215.29% | -40.31% | -420.24% | -423.05% | -2.98K% | -5.43K% |
Operating Profit Margin | -211.14% | -37.70% | -393.11% | -405.23% | -3.12K% | -5.33K% |
FCF Margin | -215.17% | -13.83% | -352.69% | -424.81% | -3.73K% | -6.92K% |
EBITDA Margin | -196.08% | -24.23% | -334.98% | -375.26% | -2.86K% | -5.24K% |
Add to Watchlist
Select watchlists to add or remove AAPG